TherapeuticsMD (TXMD) PT Lowered to $8 at Oppenheimer
Tweet
Share
E-mailGet Alerts TXMD Hot Sheet
Price: $2.24 -0.88%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on TherapeuticsMD (NASDAQ: TXMD) to $8.00 (from $9.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- Climb Bio (CLYM) PT Raised to $25 at Baird
- CIENA (CIEN) PT Lowered to $375 at Evercore ISI
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
